The programmable nuclease can replace restriction enzymes, enables cloning of large genomic sequences, and can deplete unwanted DNA species.
Heat-Seq, scheduled to launch in the second quarter, uses empirically tested molecular inversion probes.
A team of scientists believe that exosomal miRNAs holds promise to be significant biomarkers for Alzheimer's disease.
Three individuals in a 17th century burial carried genetic signatures associated with Bantu- and non-Bantu speaking populations in parts of Cameroon, Nigeria, and Ghana.
Illumina's Nextera kits and NGS technology will be used in the the National Lung Matrix Trial being run by Cancer Research UK.
Agilent Technologies said today that it has acquired Halo Genomics, a privately held Uppsala, Sweden-based provider of sample prep tools for next-generation sequencing.
By Ben Butkus
By a GenomeWeb staff reporter
Boreal's prototype platform can differentiate and enrich for sequences that differ by one nucleotide from as many as 10,000 copies of background DNA. The company believes it has potential for use in clinical applications.
Ambry is Roche NimbleGen's first service provider in the US offering the SeqCap EZ Human Exome product.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.